Comparative proteomic analysis of Staphylococcus aureus strains with differences in resistance to the cell wall‐targeting antibiotic vancomycin (original) (raw)

VanA-Type Staphylococcus aureus Strain VRSA-7 Is Partially Dependent on Vancomycin for Growth

B. Perichon

Antimicrobial Agents and Chemotherapy, 2009

View PDFchevron_right

Vancomycin resistance in Staphylococcus aureus may occur faster than expected

Kiran Tiwari

International Journal of Life Sciences, 2009

View PDFchevron_right

Genomic, Transcriptomic and Metabolomic Studies of Two Well-Characterized, Laboratory-Derived Vancomycin-Intermediate Staphylococcus aureus Strains Derived from the Same Parent Strain

Brian Wilkinson

Antibiotics, 2015

View PDFchevron_right

Novel Mechanism of Antibiotic Resistance Originating in Vancomycin-Intermediate Staphylococcus aureus

Hui-min Neoh

Antimicrobial Agents and Chemotherapy, 2006

View PDFchevron_right

Vancomycin resistance in Staphylococcus aureus may occur faster than expected

Kiran Babu Tiwari

International Journal of Life Sciences, 2009

View PDFchevron_right

Increased Glycan Chain Length Distribution and Decreased Susceptibility to Moenomycin in a Vancomycin-Resistant Staphylococcus aureus Mutant

Junko Kajimura

Antimicrobial Agents and Chemotherapy, 2002

View PDFchevron_right

Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureus

Longzhu Cui

2003

View PDFchevron_right

Mechanism of vancomycin resistance in methicillin resistant Staphylococcus aureus

Zdzislaw Markiewicz

Polish journal of microbiology / Polskie Towarzystwo Mikrobiologów = The Polish Society of Microbiologists, 2004

View PDFchevron_right

Molecular Basis of Vancomycin Dependence in VanA-Type Staphylococcus aureus VRSA-9

B. Perichon

Journal of Bacteriology, 2010

View PDFchevron_right

The D-Alanine Residues of Staphylococcus aureus Teichoic Acids Alter the Susceptibility to Vancomycin and the Activity of Autolytic Enzymes

Cuong Vuong

Antimicrobial Agents and Chemotherapy, 2000

View PDFchevron_right

Lysogenic conversion as a factor influencing the vancomycin tolerance phenomenon in Staphylococcus aureus

Dorota Zabicka

Journal of Antimicrobial Chemotherapy, 1997

View PDFchevron_right

Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50

Peter john Bennett

Journal of Antimicrobial Chemotherapy, 2002

View PDFchevron_right

Faculty of 1000 evaluation for Lack of relationship between purine biosynthesis and vancomycin resistance in Staphylococcus aureus: a cautionary tale for microarray interpretation

Lynn Silver

F1000 - Post-publication peer review of the biomedical literature, 2007

View PDFchevron_right

Cell wall-active antibiotic induced proteins of Staphylococcus aureus identified using a proteomic approach1

vineet singh

Fems Microbiology Letters, 2001

View PDFchevron_right

Global proteome analysis of vancomycin stress in Staphylococcus aureus

Gerd-martin Rappen

International Journal of Medical Microbiology, 2013

View PDFchevron_right

Microarray Transcription Analysis of Clinical Staphylococcus aureus Isolates Resistant to Vancomycin

Steven Gill

Journal of Bacteriology, 2003

View PDFchevron_right

Cell wall-active antibiotic induced proteins of Staphylococcus aureus identified using a proteomic approach 1 1 This paper is dedicated to the memory of Gerald D. Shockman, a prominent member of an earlier generation of cell wall biochemists

vineet singh

Fems Microbiology Letters, 2001

View PDFchevron_right

Demonstration of the role of cell wall homeostasis in Staphylococcus aureus growth and the action of bactericidal antibiotics

Lucia Lafage

PNAS, 2021

View PDFchevron_right

Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS

Patrice Francois

Journal of Antimicrobial Chemotherapy, 2014

View PDFchevron_right

Effect of vancomycin on the cytoplasmic membrane fatty acid profile of vancomycin-resistant and -susceptible isolates of Staphylococcus aureus

Zulfiqar Ali Mirani

View PDFchevron_right

Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility

Robert Powers

Antimicrobial agents and chemotherapy, 2018

View PDFchevron_right

Staphylococcus aureuscell wall maintenance – the multifaceted roles of peptidoglycan hydrolases in bacterial growth, fitness, and virulence

Girbe Buist

Fems Microbiology Reviews, 2022

View PDFchevron_right

Fluorescence Ratio Imaging Microscopy Shows Decreased Access of Vancomycin to Cell Wall Synthetic Sites in Vancomycin-Resistant Staphylococcus aureus

Mariana Pinho

Antimicrobial Agents and Chemotherapy, 2007

View PDFchevron_right

Staphylococcus aureus VRSA-11B Is a Constitutive Vancomycin-Resistant Mutant of Vancomycin-Dependent VRSA-11A

B. Perichon

Antimicrobial Agents and Chemotherapy, 2012

View PDFchevron_right

Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

Dalia Metwally

Clinical Microbiology Reviews, 2010

View PDFchevron_right

Contribution of a Thickened Cell Wall and Its Glutamine Nonamidated Component to the Vancomycin Resistance Expressed by Staphylococcus aureus Mu50

Longzhu Cui

Antimicrobial Agents and Chemotherapy, 2000

View PDFchevron_right

Vancomycin modifies the expression of the agr system in multidrug-resistant Staphylococcus aureus clinical isolates

José de Jesús Olivares Trejo

Frontiers in Microbiology, 2015

View PDFchevron_right

Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: PK/PD Targets for Vancomycin Exposure

Daniel Brazeau

Antimicrobial agents and chemotherapy, 2015

View PDFchevron_right